SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 253 filers reported holding SAGE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $237,237 | +11.9% | 4,925 | -2.6% | 0.00% | – |
Q1 2023 | $212,066 | +6.0% | 5,054 | -3.7% | 0.00% | – |
Q4 2022 | $200,121 | -5.6% | 5,247 | -3.1% | 0.00% | – |
Q3 2022 | $212,000 | -87.0% | 5,416 | -89.0% | 0.00% | -100.0% |
Q1 2022 | $1,627,000 | -23.9% | 49,146 | -2.2% | 0.00% | -33.3% |
Q4 2021 | $2,137,000 | -1.5% | 50,246 | +2.7% | 0.00% | 0.0% |
Q3 2021 | $2,169,000 | -3.5% | 48,946 | +23.8% | 0.00% | 0.0% |
Q2 2021 | $2,247,000 | +29.7% | 39,546 | +70.9% | 0.00% | 0.0% |
Q1 2021 | $1,732,000 | +179.8% | 23,146 | +170.0% | 0.00% | +50.0% |
Q4 2019 | $619,000 | -48.5% | 8,573 | +0.1% | 0.00% | -33.3% |
Q3 2019 | $1,202,000 | -22.7% | 8,565 | +0.8% | 0.00% | -25.0% |
Q2 2019 | $1,555,000 | +50.5% | 8,494 | +30.7% | 0.00% | +100.0% |
Q1 2019 | $1,033,000 | +289.8% | 6,497 | +135.1% | 0.00% | +100.0% |
Q4 2018 | $265,000 | -89.1% | 2,763 | -83.9% | 0.00% | -83.3% |
Q3 2018 | $2,426,000 | -1.2% | 17,175 | +9.5% | 0.01% | 0.0% |
Q2 2018 | $2,456,000 | +622.4% | 15,689 | +642.5% | 0.01% | +500.0% |
Q1 2018 | $340,000 | – | 2,113 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |